Andromeda

Andromeda

Open  for investment

About this raise: Andromeda, with a valuation of $48.5 million, is raising funds on NetCapital. The company is improving healthcare for patients with its B2B2C patient super app and marketplace and a fully integrated B2B healthcare platform. Andromeda is built as an all-in-one solution for patients and aims to improve patient satisfaction, reduce administrative costs, grow margins, and increase efficiency. The business has strategic partnerships with Optum, Gartner, and Orbit Health, has engaged in a pilot with Phy NET, and is in pilot negotiations with Northwell Health, Mount Sinai, Dispatch Health, and RightMove Health. David Vakhtangishvili founded Andromeda in May 2022. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5 million. The campaign proceeds will be used for the development of AI for AERIES, an AI-based symptom checker for patient navigation, integrations of providers, marketing, sales, compensation, conferences, business trips, and exhibitions.

Expand

Investment Overview

Committed this round: $13,850

Deal Terms

Total Commitments ($USD)

Platform
Netcapital
Start Date
12/02/2024
Close Date
02/14/2025
Min. Goal
$10,000
Max. Goal
$5,000,000
Min. Investment

$100

Security Type

Equity - Common

Series

Series A

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$50.00

Pre-Money Valuation

$48,533,300

Company & Team

Company

Year Founded
2022
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B2C
Margin
Medium
Capital Intensity
Low
Location
New York, New York
Business Type
High Growth
Company Website
Visit Website

Team

Employees
30
Prior Founder Exits?
No
Founder Name
David Vakhtangishvili
Title
CEO

Financials

as of December 31, 2023
 Revenue
$0
 Monthly Burn
$13,411
 Runway
9.1 months

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-160,935

$-37,000

Summary Balance Sheet

FY 2023 FY 2022

Cash

$121,903

$605,000

Accounts Receivable

$0

$0

Total Assets

$3,618,893

$605,000

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$3,785,000
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
02/14/2025 Netcapital $48,533,300 $13,850 Equity - Common Active RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Andromeda on NetCapital 2024
Platform: Netcapital
Security Type: Equity - Common
Valuation: $48,533,300
Price per Share: $50.00

Follow company

Follow Andromeda on NetCapital 2024

Buy Andromeda's Deal Report

Andromeda Deal Report

Get Kingscrowd's comprehensive report on Andromeda including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Andromeda is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Andromeda deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge